Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
about the author
Max Bayer
Pharma Reporter
mbayer@endpointsnews.com
author articles
Roche's cardiometabolic chief warns against weight loss 'obsession' with GLP-1s
4 months ago
Pharma
Lykos upheaval continues with four new board exits amid hunt for cash
4 months ago
People
Financing
BIO CEO plans to join FDA modernization advisory board under Trump administration
4 months ago
FDA+
Gottlieb says RFK Jr. as HHS secretary could bring ‘tragic’ outbreaks
4 months ago
People
Pharma
Lawmakers ask Biden administration to tighten rules around China clinical trials
4 months ago
China
Pharma
Lilly finances new $500M biotech fund managed by a16z
4 months ago
Financing
Pharma
John Maraganore turns to ex-Alnylam colleague to lead his latest RNAi bet; Amylyx names commercial chief
4 months ago
Peer Review
IGM Biosciences’ autoimmune pivot lasts three months after interim data disappoint
4 months ago
People
R&D
MaaT Pharma touts ‘unprecedented’ Phase 3 efficacy of graft-versus-host disease treatment
4 months ago
R&D
Pfizer, GSK add risk of Guillain-Barré to RSV vaccine labels at FDA's request
4 months ago
R&D
FDA+
After a bump in adcomms in 2023, FDA advisory panels returned to 2022 levels
4 months ago
FDA+
Pennsylvania Blue Cross insurer restricts coverage of medicines granted FDA accelerated approval
4 months ago
FDA+
Flagship biotech Valo Health ends 2024 with mid-stage fail
4 months ago
R&D
WuXi AppTec will sell cell and gene therapy business to private equity firm
5 months ago
China
Cell/Gene Tx
Three drugmakers sue US over 340B discounts to STD clinics they allege don’t qualify
5 months ago
FDA+
Law
Sumitomo’s overactive bladder drug adds another indication
5 months ago
Pharma
FDA+
Daiichi Sankyo finds successor to late R&D exec; Versant, Novartis' kidney biotech poaches Sana CBO
5 months ago
Peer Review
FDA rejects Zealand Pharma's short bowel syndrome drug
5 months ago
FDA+
Pfizer’s message to investors: The ship is steadying in 2025 (even if Washington is turbulent)
5 months ago
Pharma
FDA+
AstraZeneca is denied full FDA approval of Andexxa following critical advisory meeting
5 months ago
Pharma
FDA+
Neurocrine gets FDA go-ahead to treat rare adrenal gland condition
5 months ago
Pharma
FDA+
McKinsey hit with a $650M fine for deceiving US about opioid consulting work
5 months ago
Pharma
Law
Safety concerns and trial holds for pediatric RSV vaccines prompt caution from FDA adcomm
5 months ago
R&D
Pharma
The brain is Eli Lilly's next target for its obesity meds
5 months ago
R&D
Pharma
First page
Previous page
2
3
4
5
6
7
8
Next page
Last page
